Lixte Biotechnology Holdings Income Statement (2010-2016) | LIXT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2010	Dec2010	Mar2011	Jun2011	Sep2011	Dec2011	Mar2012	Jun2012	Sep2012	Dec2012	Mar2013	Jun2013	Sep2013	Dec2013	Mar2014	Jun2014	Sep2014	Mar2015	Jun2015	Sep2015	Dec2015	Mar2016	Jun2016	Sep2016	Dec2016
Revenue & cost
Revenue (Quarter)															-0.00M
Operating items
Depreciation & Amortization - Total (Quarter)						0.00M				0.00M				0.00M	0.00M
Research & Development (Quarter)	0.13M	-0.08M	0.26M	0.22M	0.36M	3.56M	0.27M	0.22M	0.39M	4.57M	0.17M	0.25M	0.22M	5.45M	0.16M	0.34M	0.31M	0.51M	0.29M	0.62M		0.26M	0.32M	0.34M	0.15M
Selling, General & Administrative (Quarter)	0.25M	-0.08M	0.09M	0.12M	0.13M	4.14M	0.32M	0.18M	0.44M	5.23M	0.17M	0.12M	0.09M	5.73M	0.55M	0.18M	0.19M	0.25M	0.21M	0.16M		0.15M	0.24M	0.31M	0.37M
Other Operating Expenses (Quarter)						0.05M				0.05M				0.05M	-0.00M
Operating Expenses (Quarter)	0.38M	-0.16M	0.35M	0.35M	0.50M	7.75M	0.59M	0.40M	0.84M	9.85M	0.33M	0.37M	0.31M	11.23M	0.72M	0.52M	0.50M	0.75M	0.50M	0.78M		0.42M	0.56M	0.65M	0.52M
Operating Income (Quarter)	-0.38M	0.16M	-0.35M	-0.35M	-0.50M	-7.75M	-0.59M	-0.40M	-0.84M	-9.85M	-0.33M	-0.37M	-0.31M	-11.23M	-0.72M	-0.52M	-0.50M	-0.75M	-0.50M	-0.78M		-0.42M	-0.56M	-0.65M	-0.52M
EBIT (Quarter)	-0.38M	0.16M	-0.35M	-0.35M	-0.50M	-7.75M	-0.59M	-0.40M	-0.84M	-9.85M	-0.33M	-0.37M	-0.31M	-11.23M	-0.72M	-0.52M	-0.50M	-0.75M	-0.50M	-0.78M		-0.42M	-0.56M	-0.65M	-0.52M
Non-operating items
Interest & Investment Income (Quarter)	700.00	185.00	47.00	37.00	27.00	0.03M	5.00	1.00	1.00	0.03M	1.00	1.00	1.00	0.03M	1.00	28.00	27.00	11.00	35.00	25.00		11.00	21.00	141.00	11.00
Net income details
EBT (Quarter)	-0.38M	0.16M	-0.35M	-0.35M	-0.50M	-7.72M	-0.59M	-0.40M	-0.84M	-9.83M	-0.33M	-0.37M	-0.31M	-11.20M	-0.72M	-0.52M	-0.50M	-0.75M	-0.50M	-0.78M		-0.42M	-0.55M	-0.65M	-0.52M
Profit After Tax (Quarter)	-0.38M	0.16M	-0.35M	-0.35M	-0.70M	-8.00M	-0.59M	-0.73M	-1.98M	-11.58M	-0.33M	-0.37M	-0.31M	-12.95M	-0.93M	-0.74M	-0.50M	-0.96M	-0.50M	-0.78M		-0.42M	-0.55M	-0.65M	-0.52M
Income from Continuing Operations (Quarter)	-0.38M	0.16M	-0.35M	-0.35M	-0.50M	-7.72M	-0.59M	-0.40M	-0.84M	-9.83M	-0.33M	-0.37M	-0.31M	-11.20M	-0.72M	-0.52M	-0.50M	-0.75M	-0.50M	-0.78M		-0.42M	-0.55M	-0.65M	-0.52M
Consolidated Net Income (Quarter)	-0.38M	0.16M	-0.35M	-0.35M	-0.50M	-7.72M	-0.59M	-0.40M	-0.84M	-9.83M	-0.33M	-0.37M	-0.31M	-11.20M	-0.72M	-0.52M	-0.50M	-0.75M	-0.50M	-0.78M		-0.42M	-0.55M	-0.65M	-0.52M
Income towards Parent Company (Quarter)	-0.38M	0.16M	-0.35M	-0.35M	-0.50M	-7.72M	-0.59M	-0.40M	-0.84M	-9.83M	-0.33M	-0.37M	-0.31M	-11.20M	-0.72M	-0.52M	-0.50M	-0.75M	-0.50M	-0.78M		-0.42M	-0.55M	-0.65M	-0.52M
Net Income towards Common Stockholders (Quarter)	-0.38M	0.16M	-0.35M	-0.35M	-0.50M	-7.72M	-0.59M	-0.40M	-0.84M	-9.83M	-0.33M	-0.37M	-0.31M	-11.20M	-0.72M	-0.52M	-0.50M	-0.96M	-0.50M	-0.78M		-0.42M	-0.55M	-0.65M	-0.52M
Additional items
EPS (Basic) (Quarter)	-0.01	-0.01	-0.01	-0.01	-0.02	-0.02	-0.02	-0.02	-0.05	-0.25	-0.01	-0.01	-0.01	-0.01	-0.02	-0.02	-0.01	-0.02	-0.01	-0.02	-0.01	-0.01	-0.01	-0.01	-0.01
Shares Outstanding (Weighted Average) (Quarter)		35.08M		35.26M	35.14M	35.17M	35.32M	36.37M	41.56M	38.99M	41.58M	41.58M	41.58M	41.58M	41.58M	2.93M	45.48M	45.50M	46.71M	46.43M	46.79M	47.88M	47.88M	47.88M
EBITDA (Quarter)	-0.38M	0.16M	-0.35M	-0.35M	-0.50M	-7.75M	-0.59M	-0.40M	-0.84M	-9.85M	-0.33M	-0.37M	-0.31M	-11.23M	-0.71M	-0.52M	-0.50M	-0.75M	-0.50M	-0.78M		-0.42M	-0.56M	-0.65M	-0.52M
Interest Expenses (Quarter)						0.00M				0.00M				0.00M	0.00M

Research Tools

Lixte Biotechnology Holdings Income Statement (2010-2016) | LIXT

Create an account

Sign In

Reset Password